Documents & Downloads

Other Forms

Form	MW
Tezacitabine hydrate This page	275.23
Tezacitabine	257.22

Tezacitabine hydrate

Ribonucleotide Reductase Inhibitor

Tezacitabine hydrate is a potent ribonucleotide reductase inhibitor that exhibits both cytostatic and cytotoxic properties as a nucleoside analogue. By irreversibly inhibiting ribonucleotide reductase, it disrupts DNA replication and repair processes, effectively inducing apoptosis in target cells. Tezacitabine hydrate shows promise for therapeutic applications in the treatment of leukemias and various solid tumors, including carcinomas.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	171176-43-5
Applications	Ribonucleotide Reductase Inhibitor
Formula	C₁₀H₁₄FN₃O₅
Molecular Weight	275.23
SMILES	O[C@H]([C@@H](CO)O[C@H]/1N2C(N=C(C=C2)N)=O)C1=C/F.O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.